Department of Medicine and Naomi Berrie Diabetes Center, Vagelos College of Physicians & Surgeons of Columbia University, New York, NY, USA.
Nat Metab. 2021 Feb;3(2):123-125. doi: 10.1038/s42255-020-00339-7.
The prevalence of COVID-19-associated diabetes is not the result of a single event but of a combination of disease susceptibility associated with chronic illness and COVID-19-specific mechanisms affecting metabolism. Whether a separate entity of post-COVID-19 diabetes, possibly associated with lasting β-cell damage, also exists is not yet clear.
COVID-19 相关糖尿病的患病率不是单一事件的结果，而是与慢性疾病相关的疾病易感性和影响代谢的 COVID-19 特异性机制的组合。尚不清楚是否存在 COVID-19 后糖尿病的另一个独立实体，可能与持续的β细胞损伤有关。
